Antianginal efficacy of the combination of trimetazidine-propranolol compared with isosorbide dinitrate-propranolol in patients with stable angina

Clinical Drug Investigation

Volumn 13, Issue 1, 1997, Pages 8-14

  Michaelides, Andreas P ^a,c   Spiropoulos, Konstantinos ^a   Dimopoulos, Konstantinos ^b   Athanasiades, Demetrios ^b   Tontouzas, Pavlos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b RED CROSS HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGINA PECTORIS AGENT; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; PROPRANOLOL; TRIMETAZIDINE;

ANGINA PECTORIS; ARTICLE; BICYCLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG USE; EXERCISE TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION; TREADMILL; WORKLOAD;

EID: 0031028751     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199713010-00002     Document Type: Article

References (32)

1. Boddeke E, Hugtenburg J, Jap W, W, et. New anti-ischaemic drugs: cytoprotective action with no primary haemodynamic effects. TIPS 1989; 10: 397-400
2. Detry JM. Clinical features of an anti-anginal drug in angina pectoris. Eur Heart J 1993; 14 Suppl. G: 18-24
3. Koher G, Buck T, Sievert H, et al. Myocardial cytoprotection during percutaneous transluminal coronary angioplasty: effect of trimetazidine. Eur Heart J 1992; 13: 1109-15
4. Fabiani JN, Ponzio O, Emerit I, et al. Cardioprotective effect of trimetazidine during coronary artery graft surgery. J Cardiovasc Surg 1992; 33: 486-91
5. Brottier L, Barat JL, Combe L, et al. Therapeutic value of a eardioprotective agent in patients with severe cardiomyopathy. Eur Heart J 1990; 11: 207-12
6. De Leiris J, Boucher F. Rationale for trimetazidine administration in myocardial ischaemia - reperfusion syndrome. Eur Heart J 1993; 14 Suppl. G: 34-40
7. Sellier P. Effets de la trimétazidine sur les paramètres ergométriques dans l'angor d'effort. Etude multicentrique contrôlée à double insu contre placebo. Arch Mal Coeur 1986; 79(9): 1331-6
8. Prasad R, Singh HK. The efficacy of trimetazidine in stable effort angina. A double-blind placebo controlled study. Indian Med J 1989; 83 (3): 54-8
9. Dalla-Volta S, Maraglino G, Della-Valentina B, et al. Comparison of trimetazidine with nifedipine in effort angina: a double-blind, cross-over study. Cardiovasc Drug Ther 1990; 4 (4): 853-60
10. Detry JM. Sellier P, Pennaforte S. et al. Trimetazidine: a new concept in the treatment of angina - comparison with propranolol in patients with stable angina. Br J Clin Pharmacol 1994; 37(3): 279-88
11. Frischman WH. β-Adrenoreceptor antagonists: new drugs and new indications. New Engl J Med 1981; 305: 500-6
12. Bernard R, Eliasch H, Gonin A, et al. Nomenclature and criteria 2 for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force for standardization of clinical nomenclature. Circulation 1979; 59: 607-9
13. Campeau L. Grading of angina pectoris. Circulation 1976; 54: 522
14. Chierchia S, Muisean L, Davies A, et al. Role of the sympathetic nervous system in the pathogenesis of chronic stable angina. Circulation 1990; 82 Suppl. 11: 1171-118
15. Svendsen JH, Amtorp A. Mononitrates in combination with beta-blocker therapy in the treament of severe angina pectoris. Drugs 1987; 33 Suppl. 4: 122-4
16. Michaelides AP, Vyssoulis GP, Bonoris PE, et al. Beneficial effects of trimetazidine in man with stabla angina under beta-blocker treatments. Curr Ther Res 1989; 46 (3): 565-76
17. Delaye J. Le phénomène de l'échappement dans la pratique thérapeutique de l'angine de poitrine. Presse Med 1988; 17: 996-9
18. Weidemann H, Schuon J, Schober B., et al. Hemodynamic measurements and exercise testing to assess the development of tolerance against slow release isosorbide dinitrate. Z Kardiol 1983; 72: 229-32
19. Pornin M, Harpey C, Allal J, et al. Lack of effects of trimelazidine on systemic hemodynamics in patients with coronary artery disease: a placebo controlled study, Clin Trials Meta-Anal 1994; 29: 49-56
20. Boucher F, Hearse D. Opie L. Effects of trimetazidine on ischemic contracture in isolated perfused rat hearts. J Cardiovasc Pharmacol 1994; 24: 45-9
21. Belcher P, Drake-Holland AJ, Hynd JW, et al. Trimetazidine reduces myocardial infarct size, relative to area at risk, after temporary coronary artery occlusion in the rabbit. Br J Pharmacol 1992; 107: 265
22. Chierchia SL, Fragasso G. Metabolic management of ischaemic heart disease. Eur Heart J 1993; 14 Suppl. G: 2-5
23. Hugtenburg JG, Jap TSW, Mably JJ, et al. Cardioprotective effect of trimetazidine and nifedipine in guinea-pig hearts subjected to ischemia. Arch Int Pharmacodyn Ther 1989; 300: 186-208
24. Lavanchy N, Martin J, Rossi A. Antiischemic effects of trimetazidine: 31P-NMR spectroscopy in the isolated rat heart. Arch Int Pharmacodyn Ther 1987; 286: 97-110
25. Aussedat J. Ray A, Kay L, et al. Improvement of long-term preservation of isolated arrested rat heart: beneficial effect of the antiischemic agent trimetazidine. J Cardiovasc Pharmacol 1993; 21 (6): 128-35
26. Williams FM, Tanda K, Williams TJ. Trimetazidine inhibits neutrophil accumulation after myocardial ischemia and reperfusion in rabbits. J Cardiovasc Pharmacol 1993; 22: 828-33
27. Maupoil V, Rochette L, Tabard A, et al. Evolution of free radical formation during low-flow ischemia and reperfusion in isolated rat heart. Cardiovasc Drugs Ther 1990; 4: 791-6
28. Fantini E, Demaison L, Sentex E, et al. Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation. J Moll Cell Cardiol 1994; 26: 949-58
29. Lagadic-Gossmann D, Le Prigent K, Feuvray D. Effects of trimetazidine on pHi regulation in the rat isolated ventricular myocyte. Br J Pharmacol 1996; 117: 831-8
30. Gobel FL, Nordstrom LA, Nelson RR, et al. The rate pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation 1978; 57: 549-54
31. Myers J, Proelicher VF. Optimizing the exercise test for pharmacological investigations. Circulation 1990; 82: 1839-46
32. Northride DB, Grant S, Ford I, et al. Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer. Br Heart J 1990; 64: 331-6